The biotech industry is at a crossroads, grappling with the challenges and expectations set by cell therapies. Oncology-focused treatments that once held great promise are now facing a reality check, prompting many companies to reevaluate their focus on autoimmune diseases. As expectations align
Precision medicine is not only revolutionizing our approach to illness but also reshaping how we think about preventing chronic diseases and extending life expectancy. Dr. Florence Comite's insights offer clear guidance on how dietary choices can influence our healthspan, the part of our lives
A Pioneering Approach to Targeted Treatment The quest for effective cancer treatments and vaccines has led to a potentially groundbreaking development: EnGeneIC's Endosomal Disruption Vector (EDV) technology. As a Sydney-based biotech innovator, EnGeneIC has been pushing the boundaries of medical
In the ongoing battle against contagious diseases, researchers at the Innovation Center of NanoMedicine's Uchida Laboratory have made a significant breakthrough with the creation of a "naked mRNA" vaccine. This innovative technology harnesses messenger RNA to invoke an immune response without the
The fusion of genetic and clinical data holds significant promise for treating inheritable diseases caused by mutations in germ cells. As genetic nuances greatly affect disease manifestation and treatment response, a one-size-fits-all approach is inadequate. Clinico-genomic integration offers a
Medicine is witnessing a sea change with precision medicine at the helm, especially within cardiac health. Customized treatments based on a patient’s genetic makeup are becoming the norm, thanks to clinico-genomic data, a blend of clinical history and genetic information. This data is invaluable
